Results 21 to 30 of about 298,741 (199)

Life cycle heterogeneity in animal models of human papillomavirus-associated disease [PDF]

, 2002
Animal papillomaviruses are widely used as models to study papillomavirus infection in humans despite differences in genome organization and tissue tropism. Here, we have investigated the extent to which animal models of papillomavirus infection resemble
Peh, W.L., Liu, W.J., Christensen, N., Egawa, K., Lewis, J., Christensen, Neil, Peh, Woei Ling, Egawa, Kiyofumi, Percival, Alan, Lewis, Jon, Liu, Wen Jun, Percival, A., Nicholls, Philip, Doorbar, J., Brandsma, Janet, Middleton, K., Nicholls, P.K., Brandsma, J., Middleton, Kate, Sotlar, Karl, Sotlar, K., Doorbar, John   +21 more
core   +1 more source

Detection and genotyping of human Papillomavirus in urine samples from unvaccinated male and female adolescents in Italy [PDF]

, 2013
The introduction of vaccination against Human Papillomavirus (HPV) in adolescent girls in 2006 has focused virological surveillance on this age group. As few studies have evaluated HPV infections in young populations, further data are needed in order to ...
Zotti, CM, Boccalini, Sara, Elisabetta Tanzi, Gasparini Roberto, Coppola Rosa Cristina, R. Gasparini, Rosa Cristina Coppola, Coppola, RC, Gasparini R, Paolo Castiglia, M. Martinelli, M. Martinese, Panatto D, Silvia Bianchi, Amicizia, D, Amicizia D, Paolo Bonanni, Zotti CM, Elena Rosanna Frati, Bianchi S, Bianchi, S, Martinelli, M, Castiglia Paolo, Bianchi Silvia, D. Panatto, Marianna Martinelli, Meloni, Angelo, Tanzi Elisabetta, Amicizia, Daniela, G. Masia, Masia Giuseppina, Zotti, Carla Maria, Bianchi, Silvia, Daniela Amicizia, Bonanni, Paolo, Martinese M, Martinese, M, Masia G, Castiglia, Paolo Giuseppino, Tanzi, Elisabetta, S. Bianchi, Morena Martinese, C. M. Zotti, P. Castiglia, Coppola R C, Boccalini, S, Amicizia Daniela, Boccalini S, Martinelli Marianna, Bonanni Paolo, Bonanni P, Panatto, Donatella, Panatto Donatella, Frati, ER, Tanzi E, Zotti Carla Maria, Martinelli, Marianna, Frati ER, Piana Andrea, Tanzi, E., Piana A, Martinese, Morena, Gasparini, Roberto, Gasparini, R, Castiglia P, Donatella Panatto, Meloni Angelo, Martinese Morena, Sara Boccalini, D. Amicizia, E. Tanzi, Andrea Piana, P. Bonanni, Panatto, D, Meloni, A, Frati, Elena Rosanna, Masia, Giuseppina, Piana, Andrea Fausto, Boccalini Sara, Giuseppina Masia, R. C. Coppola, A. Meloni, E.R. Frati, Angelo Meloni, S. Boccalini, Roberto Gasparini, Frati Elena Rosanna, Masia, G, A. Piana, Martinelli M, Coppola, Rosa Cristina, Meloni A, Carla Maria Zotti, Bonanni, P   +93 more
core   +2 more sources

Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review

Acta Médica Portuguesa, 2020
Introduction: Human papillomavirus is responsible for almost all cases of cervical cancer, an important portion of anogenital and oropharyngeal invasive and preinvasive lesions, as well as genital warts (condyloma acuminatum) and recurrent respiratory ...
Rita Medeiros, Susan Vaz, Teresa Rebelo, Margarida Figueiredo-Dias   +3 more
doaj   +1 more source

A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections. [PDF]

PLoS ONE, 2015
Papillomavirus disease and associated cancers remain a significant health burden in much of the world. The current protective vaccines, Gardasil and Cervarix, are expensive and not readily available to the underprivileged.
Nancy M Cladel, Lynn R Budgeon, Karla K Balogh, Timothy K Cooper, Jiafen Hu, Neil D Christensen   +5 more
doaj   +1 more source

Cost‐effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India

, 2023
Background Human papillomavirus (HPV) vaccines represent an important strategic opportunity to prevent cervical cancer in low-middle income countries, such as India.
Tuffaha, Haitham, Haitham Tuffaha, Shiksha Arora, Arora, Shiksha   +3 more
core   +1 more source

The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review [PDF]

, 2021
Cervical cancer is recognized as a serious public health problem since it remains one of the most common cancers with a high mortality rate among women despite existing preventative, screening, and treatment approaches.
Ayazhan Akhatova, Azliyati Azizan, Chee Kai Chan, Akhatova, Ayazhan, Kai Chan, Chee, Gulzhanat Aimagambetova, Chan, Chee Kai, Azizan, Azliyati, Aimagambetova, Gulzhanat   +8 more
core   +1 more source

Eliminat Cervical Cancer, Focusing on Primary Prevention

Zhongliu Fangzhi Yanjiu, 2023
As one of the most severe malignant tumors, cervical cancer poses a significant threat to women. In 2020, the World Health Organization (WHO) introduced the "Global Strategy to Accelerate the Elimination of Cervical Cancer" in response to well ...
ZHAO Chao, LI Mingzhu, WEI Lihui
doaj   +1 more source

Plant production and immunogenic characterisation of Human papillomavirus chimaeric vaccines [PDF]

, 2011
Includes abstract.Includes bibliographical references (leaves 153-175).Cervical cancer is primarily caused by infection with Human papillomavirus (HPV) and is a global concern, particularly in developing countries which contain ~80% of the cervical ...
Pineo, Catherine
core   +1 more source

A cohort survey of the effect of an educational intervention on human papillomavirus vaccine-related knowledge and attitudes among pre-university female students in Singapore

Proceedings of Singapore Healthcare, 2017
Introduction: Although cervical cancer is the 10th most common cancer among females in Singapore, it is a vaccine-preventable cancer. Human papillomavirus vaccines combined with regular Pap (papillomavirus) smears have been shown to reduce the mortality ...
Sarah Woon Ching Lim, Alicia Ying Ying Boo, Wee Chuan Tan, Eunice Su-Yin Png, Hang Keong Lee, Zi Ying Chang, Serene Xue Jia Wee, Brindha Balakrishnan, Kuan Siew Choong, Ian Kwong Yun Phoon   +9 more
doaj   +1 more source

Economic evaluation of human papillomavirus vaccination in the United Kingdom. [PDF]

, 2008
OBJECTIVE: To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. DESIGN: Economic evaluation. SETTING: UK. Population Schoolgirls aged 12 or older.
Choi, Yoon Hong, Jit, Mark, Edmunds, W John   +2 more
core   +1 more source